Quarterly CFO
N/A
30 September 2023
Summary:
Tekla Life Sciences Investors quarterly cash flow from operations is not available.HQL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
N/A
30 September 2023
Summary:
Tekla Life Sciences Investors TTM cash flow from operations is not available.HQL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HQL Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
HQL Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
Tekla Life Sciences Investors Cash From Operations History
Date | Annual | Quarterly | TTM |
---|
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 1998 | - | -$1.75 M | -$1.75 M |
FAQ
- What is the all time high quarterly CFO for Tekla Life Sciences Investors?
- What is the all time high TTM CFO for Tekla Life Sciences Investors?
What is the all time high quarterly CFO for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly cash flow from operations is -$1.75 M
What is the all time high TTM CFO for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high TTM cash flow from operations is -$1.75 M